期刊文献+

缬沙坦氨氯地平片对老年高血压患者血压的影响 被引量:1

Effect of valsartan amlodipine tablets on blood pressure in elderly patients with hypertension
下载PDF
导出
摘要 目的:探讨缬沙坦氨氯地平片对老年高血压患者血压的影响。方法:收治老年高血压患者188例,随机分成观察组和对照组各94例。对照组给予甲磺酸氨氯地平片治疗。观察组给予缬沙坦氨氯地平片治疗。比较两组患者的血压及相关指标。结果:两组患者的TC、DBP、SBP比较,差异具有统计学意义(P<0.05)。结论:缬沙坦氨氯地平片治疗老年高血压效果显著。 Objective:To explore the effect of valsartan amlodipine tablets on blood pressure in elderly patients with hypertension.Methods:188 elderly patients with hypertension were selected.They were randomly divided into the observation group and thecontrol group with 94 cases in each.The control group was treated with amlodipine mesylate tablets.The observation group wastreated with valsartan amlodipine tablets.The blood pressures and related indexes of two groups were compared.Results:The TC、DBP、SBP of two groups were compared,the differences were statistically significant(P<0.05).Conclusion:The effect of valsartanamlodipine tablets in the treatment of elderly hypertension is remarkable.
作者 古丽娜.买买提明 热娜古丽.阿不都克里木 Gulina·Maimaitiming;Renaguli·Abudukelimu(The Traditional Chinese Medicine Hospital of Urumqi Municipality,Xinjiang 830000;The Worker's Hospital of Xinjiang Oil Field Company Zhundong Oil Production Factory 831500)
出处 《中国社区医师》 2015年第34期20-20,22,共2页 Chinese Community Doctors
关键词 缬沙坦氨氯地平片 老年 高血压 Valsartan amlodipine tablets Elderly Hypertension
  • 相关文献

参考文献2

二级参考文献24

  • 1戚文航,潘长玉,林善琰.我国部分地区高血压登记调查及治疗达标研究[J].中华心血管病杂志,2007,35(5):457-460. 被引量:46
  • 2Murray C J, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study[J]. Lancet, 1997, 349: 1269-1276. 被引量:1
  • 3Wu Z, Yao C, Zhao D, et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring [J]. Circulation, 2001, 103: 462-465. 被引量:1
  • 4Kannel WB, Sorlie P, Gordon T. Labile hypertension: a faulty concept? The Framingham study [ J ]. Circulation, 1980, 61:1183-1187. 被引量:1
  • 5Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults [J]. Circulation, 2004, 110: 1245-1250. 被引量:1
  • 6Mule G, Cottone S, Mongiovi R, et al. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients [J]. Nutr Metab Cardiovasc Dis, 2006, 16:54-59. 被引量:1
  • 7O'Donnell CJ, Elosua R. Cardiovascular risk factors: insights from Framingham Heart Study [J]. Rev Esp Cardiol, 2008, 61: 299-310. 被引量:1
  • 8Fox C, Coady S, Sorlie P, et al. Trends in cardiovascular complications of diabetes [J]. JAMA, 2004, 292: 2495-2499. 被引量:1
  • 9Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results Ⅱ: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering [J]. JAMA, 1984, 251: 365-374. 被引量:1
  • 10Iori I, Gatati G, Fusco MA, et al. Survey of cardiovascular risk factors in overweight and obese patients (SCOOP Study): six-month chages in risk factor levels and cardiovascular risk [J]. Euro J Inter Med, 2009, 20: 280-288. 被引量:1

共引文献57

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部